[Event Report] The Global Expert Meeting “The Future of the Olympic Games–The Policies Needed to Resume Large-Scale International Events” (March 5, 2021)
date : 4/5/2021
Tags: Other activities, Vaccinations
******** The full report published April 5, 2021.
For more information, please refer to the PDF.
■Overview:
Health and Global Policy Institute (HGPI) will take advantage of its position as a neutral and independent global think tank to convene the COVID-19 Policy Agenda Series, a series of global expert meetings for discussing future COVID-19 measures with experts from abroad.
These meetings will provide opportunities for those experts to freely exchange opinions from positions of equality on best methods to promote immunization among the public, how to communicate to the public, the current status of surveillance and testing systems, efforts to improve policies, and the ideal structure of international quarantine and inspection systems. This knowledge will be required to hold the 2021 Tokyo Olympic and Paralympic Games and other international events, to enable the Government to effectively communicate risk to the public, and to improve epidemiological database systems. In the future, we will make efforts to connect with experts around the world online to create more opportunities for international opinion exchanges.
At the first expert meeting, we deepened the discussion on advances that must be made to reach a national consensus on hosting large-scale international events, establishing systems for international collaboration, and policy developments needed to safely resume large-scale international events with the Tokyo Olympic and Paralympic Games in mind.
■Five recommendations synthesized from an international discussion involving industry, the Government, academia, and civil society (Summary):
Recommendation 1. To resume large-scale events, public understanding of all aspects of COVID-19 control should be promoted.
Recommendation 2. Quarantining at international points of entry and thorough observance of basic infectious disease control measures should continue. negative test results at time of departure or entry are not decisive infectious disease control measures.
Recommendation 3. A data-based infection management system that utilizes epidemiological databases and modeling should be built.
Recommendation 4. Testing systems should be diversified and expanded according to scientific knowledge.
Recommendation 5. The Tokyo Olympic and Paralympic Games should be held in a manner that demonstrates the new normal to the world.
(For more information, please refer to the PDF)
■Speakers (Title Omitted):
Hanako Jimi (Member, House of Councilors; Chief of Secretariat, Anti-COVID-19 Measures for Inbound Tourists at Head Office, the Novel Coronavirus Response Headquarters of the Liberal Democratic Party of Japan))
Cheong Wei Yang (Deputy Secretary (Special Projects), Ministry of Health, Singapore)
Alex Richard Cook (Associate Professor, at National University of Singapore, Saw Swee Hock School of Public Health)
Satoshi Kamayachi (Executive Director, Japan Medical Association)
Nobuhiko Okabe (Director General, Kawasaki City Institute for Public Health)
Naomi Sakurai (Cancer survivor; President, Cancer Solutions Co., Ltd)
Katsunori Yanagihara (Professor, Department of Laboratory Medicine, School of Dentistry and Pharmaceutical Sciences, Nagasaki University; Examination and Diagnosis Team, Tokyo Center for Infectious Disease Control and Prevention (iCDC) Expert Board)
Hidemasa Nakamura (GDO<Games Delivery Officer> / Executive Director of Sports, The Tokyo Organising Committee of the Olympic and Paralympic Games)
Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University; President, The Japanese Society for Clinical Microbiology)
Keizo Takemi (Member, House of Councilors; Chairperson, Infectious Disease Measures Governance Subcommittee, the Novel Coronavirus Response Headquarters of the Liberal Democratic Party of Japan)
Kiyoshi Kurokawa (Chairman, HGPI)
Ryoji Noritake (CEO, Board Member, HGPI)
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



